Autism spectrum disorders following in utero exposure to antiepileptic drugs

Neurology

Volumn 73, Issue 12, 2009, Pages 997-

  Evatt, M L ^a   Delong, M R ^a   Grant, W B ^a   Cannell, J J ^a   Tangpricha, V ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ANTICONVULSIVE AGENT; OXYGENASE; PREGNANE X RECEPTOR; VALPROIC ACID; VITAMIN D;

AUTISM; DISEASE ASSOCIATION; DRUG RECEPTOR BINDING; EPILEPSY; HUMAN; LETTER; MOLECULAR MECHANICS; PHENOTYPE; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGENY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

EID: 70349673169     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181af0b95     Document Type: Letter

References (5)

1. Bromley RL, Mawer G, Clayton-Smith J, Baker GA, on behalf of the Liverpool and Manchester Neurodevelop-ment Group. Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 2008;71: 1923-1924.
2. Kulak CA, Borba VZ, Bilezikian JP, Silvado CE, Paola L, Boguszewski CL. Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs. Arq Neuropsiquiatr 2004;62:940-948.
3. Markestad T, Ulstein M, Strandjord RE, Aksnes L, Aars-kog D. Anticonvulsant drug therapy in human pregnancy: effects on serum concentrations of vitamin D metabolites in maternal and cord blood. Am J Obstet Gynecol 1984; 150:254-258.
4. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-281.
5. Cannell JJ. Autism and vitamin D. Med Hypotheses 2008; 70:750-759.